678 results found | searching for "pharma"

First Previous 5 6 7 8 9 10 11 12 13 14 Next Last 
  • 5starelk
  • What is more, due to such a lot of confusion revolving around High-Risk Merchant Account Online Pharmacy or low-risk accounts, it may very well be trying to find a high-risk merchant administration. https://writeupcafe.com/all-about-high-risk-merchant-account-online-pharmacy/ [more]
  • jameshebrew
  • Oral Proteins and Peptides Market Over the years, advances in recombinant DNA technology and ex vivo synthesis of biomolecules have led to the development and (in some cases) approval of several protein / peptide-based therapeutics. Considering the therapeutic advantages associated with proteins and peptides, this field has witnessed significant activity; researchers are actively evaluating orally bioavailable interventions. However, owing to their inherently complex structure and comparatively low stability (in in vivo conditions), proteins / peptides are predominantly administered parenterally. Recent strides in drug delivery solutions have enabled scientists to successfully explore and exploit alternative routes of drug delivery, such as transdermal, intranasal, pulmonary and oral, for protein / peptide-based therapeutics. Of these, the oral route of delivery is considered to be the most patient-friendly. This has led several companies to invest in the development of orally administered biologics. The delivery of proteins and peptides utilizes the following routes of administration. Since the approval of the first protein / peptide-based therapy (recombinant human insulin) in 1982, there has been a substantial increase in the R&D initiatives focused on such products. Earlier, majority of the biologics were administered subcutaneously. However, with the technological advancements in delivery formulations, oral delivery of therapeutic interventions has gained significant traction, prompting stakeholders to leverage their expertise in the development of orally administrable proteins / peptides. To request a sample copy / brochure of this report, please visit https://www.rootsanalysis.com/reports/192/request-sample.html Although studies have reported that over XX oral drug delivery technologies have been designed so far, our research indicates that only XX% of the aforementioned technologies are currently being used to develop therapeutic proteins / peptides. Owing to the numerous advantages of oral drug delivery, including ease of administration, minimal pain and risk of drug reaction, and self-administration, we are led to believe that the oral proteins / peptide therapeutics market is anticipated to witness significant growth in the coming future. For additional details, please visit https://www.rootsanalysis.com/reports/view_document/oral-proteins-and-peptides-market/192.html or email sales@rootsanalysis.com You may also be interested in the following titles: 1. Targeted protein degradation market, 2022-2035 2. Cell Therapy Manufacturing Market, 2021-2030 3. Single-Use Upstream Bioprocessing Technology / Equipment Market, 2022-2035 About Roots Analysis Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com Contact: Ben Johnson +1 (415) 800 3415 +44 (122) 391 1091 Ben.johnson@rootsanalysis.com Facebook - https://www.facebook.com/RootsAnalysis LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/ Twitter - https://twitter.com/RootsAnalysis Medium - https://medium.com/@RootsAnalysis Pinterest - https://in.pinterest.com/RootsanalysisPin/_saved/ Quora - https://rootsanalysisinsights.quora.com/ [more]
  • techt
  • Hetaksh Essential Oils are Top-notch Arachis Oil BP Grade Manufacturers, Suppliers and Exporters from India. We provide the best quality oil as per Food Grade, pharma grade, and Cosmetic Grade. visit site: https://hetakshessentialoils.com/product/arachis-oil
  • arif12
  • Single-Use Bioprocessing Market Research Report Size, Share & Growth & Global Forecast 2021-2028 The factors driving the growth of Single Use Bioprocessing Market includes growing demand for biopharmaceutical products, rise in the geriatric population, emerging need to reduce water wastage and increasing environment and economic concerns round the world. According to the report published by Statista, the Global Biopharmaceutical Market was calculated around USD 345.8 billion in 2021 and is predicted to reach USD 974.5 billion by the end of 2030, which is expected to boost the Single Use Bioprocessing Market size in the approaching years. For More Info, Click to Access Complete Report – https://www.snapigram.com/read-blog/70388 [more]
  • arif12
  • Single-Use Bioprocessing Market Research Report Size, Share & Growth & Global Forecast 2021-2028 Single-Use Bioprocessing Market is projected to touch USD 30,250 million by 2028, increasing 20.5% CAGR during the forecast period (2021-2028), due to the growing demand for pharmaceutical products. For More Info, Click to Access Complete Report – https://descubre.beqbe.com/single-use-bioprocessing-market [more]
  • arif12
  • Artificial Intelligence in Drug Discovery Market Research Report Size, Report & Forecast, 2020-2027 The AI In Drug Discovery Market was estimated around USD 243 million in 2019 and is predicted to expand at a CAGR of 39.6% over the forecast period (2020-2027). The factors driving the growth of AI In Drug Discovery Market growing adoption of Artificial Intelligence based solutions for preclinical trials phase, rise in the number chronic diseases such as diabetes and heart related diseases around the world and expansion of the pharmaceutical industry. For More Info, Click to Access Complete Report – https://arif57.bcz.com/2022/10/19/artificial-intelligence-in-drug-discovery-market-research-report-size-report-forecast-2020-2027/ [more]
  • Lorcheem
  • Rumored Buzz Best gaming store https://pharmatalk.org/Creimash [more]
  • jameshebrew
  • The cell invasion and migration assays market is projected to grow at a CAGR of 8% In recent years, the potential of cell invasion and migration assays with respect to discovery, diagnosis and screening of diseases has been widely recognized, which has further presented lucrative opportunities for players offering such products. London Roots Analysis has announced the addition of the “Cell Invasion and Migration Assays Market, 2022–2035” report to its list of offerings. Owing to several advantages offered by cell invasion and migration assays in analyzing and quantifying cellular mechanisms, industry stakeholders have undertaken numerous R&D initiatives focused on exploiting the use of such assays to expediate discovery timelines and optimize the total development cost. Considering the various advantages offered by these cell-based assays, researchers across the globe have undertaken several initiatives to use these platforms for the diagnosis of a myriad of disease indications. The advancements in various technologies have propelled life science companies to use these assays in the drug discovery process, to enable the identification of potential lead candidates. To request a sample copy / brochure of this report, please visit this https://www.rootsanalysis.com/reports/cell-invasion-and-migration-assays-market/request-sample.html Key Market Insights Presently, more than 80% of the total assay providers are based in North America This segment of the industry is dominated by the presence of companies that were established pre-2000 (64%), followed by firms established during 2000-2010 (27%). In addition, most of the players engaged in this domain are small firms (less than 100 employees), representing over 45% of the total assay providers. Currently, over 80 cell invasion and migration assays are available in the market It is worth noting that most of the cell invasion and migration assays are currently being used for tumor studies (89%), followed by those employed for screening purposes (79%). Further, most of the assays are being developed for adherent cell cultures (48%), followed by those being manufactured for both adherent and suspension cell cultures (40%). 55% players claim to be capable of offering both cell invasion as well as cell migration assays 64% of the cell invasion and migration assays can be stored under frozen temperature (-18°C to -40°C), followed by those stored under refrigerated conditions (+1°C to +18°C) (36%). Further, it is worth noting that most of the cell invasion and migration assays are being used to conduct 100 tests (37%). This was followed by assays being developed to conduct 12 (35%) and 96 tests (23%). Over 650 articles focused on cell invasion and migration assays have been published, since 2021 Majority of the scientific literature published in this domain was focused on research (96%), followed by review articles (4%). It is worth mentioning that articles related to cell invasion and migration assays have been affiliated by over 300 universities. Patents filed / granted for cell invasion and migration assays have increased at a CAGR of more than 45%, since 2017 Of the total, around 55% of the patents were applications, followed by those that have been granted approval (45%). Around 63% of these intellectual property documents were filed / granted in North America; with the maximum number of patents having been filed in the US, since 2017. For additional details, please visit https://www.rootsanalysis.com/reports/cell-invasion-and-migration-assays-market.html You may also be interested in the following titles: 1. Targeted protein degradation market, 2022-2035 2. Cell Therapy Manufacturing Market, 2021-2030 3. Single-Use Upstream Bioprocessing Technology / Equipment Market, 2022-2035 About Roots Analysis Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com Contact: Ben Johnson +1 (415) 800 3415 +44 (122) 391 1091 Ben.johnson@rootsanalysis.com Facebook - https://www.facebook.com/RootsAnalysis LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/ Twitter - https://twitter.com/RootsAnalysis Medium - https://medium.com/@RootsAnalysis Pinterest - https://in.pinterest.com/RootsanalysisPin/_saved/ Quora - https://rootsanalysisinsights.quora.com/ [more]
  • globalpharma
  • Pharmaceutical Wholesale Distributor @ Global Pharma Distributor Global pharma distributor is a pharmaceutical wholesale distributor in the UK with the goal of providing affordable healthcare to every person on this planet. Contact us today! https://www.globalpharmadistributoruk.com/about-us
  • jameshebrew
  • The RNA sequencing services market is anticipated to grow at a CAGR of ~8% by 2035 In order to avail benefits, such as technical competence in sequencing large-sized genes, reduced cost, and fast delivery of high-quality data, researchers and industry players have demonstrated a preference to outsource RNA sequencing. London Roots Analysis has announced the addition of “RNA Sequencing Services Market, 2022-2035” report to its list of offerings. Despite the various technological advancements in RNA sequencing, there are several existing challenges, including difficulty in the sequencing of large-sized genes, shortage of human resources, lack of tools for data manipulation and analysis, and high capital requirement. In order to overcome these challenges and obtain a high-quality output, the outsourcing of RNA sequencing is considered as a preferable option, among other alternatives, by the companies engaged in RNA sequencing. To request a sample copy / brochure of this report, please visit https://www.rootsanalysis.com/reports/rna-sequencing-services-market/request-sample.html Key Market Insights Currently, more than 70 companies claim to offer RNA sequencing services, globally Nearly 70% of the RNA sequencing service providers have been established post 2000, most of these are located in North America (58%) followed by Europe (22%). Further this segment of the industry is dominated by presence of mid-sized players (51-1,000 employees), representing 44% of the total service providers. Nearly 75% of the companies employ Illumina’s sequencing platform Of these, nearly 20% players offer services related to small RNA sequencing, followed by those offering services for mRNA sequencing (19%). Further, more than 80% of players claim to offer turnaround time of less than two weeks for different types of RNA sequencing services. Close to 1,050 grants have been awarded to support the research initiatives focused on RNA sequencing, since 2018 Grants worth USD 487 million have been awarded to various companies / organizations working in this domain. Close to 85% of the grants have been awarded for less than five years, out of which 15% grants were funded by the National Cancer Institute. Over 340 patents related to RNA sequencing have been filed / granted, since 2018 Owing to the increase in research and development efforts by various industry and non-industry players engaged in this domain, close to 87% of patent applications have been filed post-2018. It is worth noting that 58% patents related to RNA sequencing were filed / granted in Asia Pacific, alone. Presently, more than 85 NGS library preparation kits are available in market for RNA sequencing Majority (75%) of the kits offer turnaround time of less than five hours, out of which 80% kits contain enzyme mix as components. Further, most of the kits (40%) use plasma as the starting material, followed by kits that use serum (34%) and saliva (8%) as input samples. North America and Europe are anticipated to capture larger share (~70%) of the market by 2035 The market will be primarily driven by RNA sequencing for research purposes (93%). Further, clinics and hospitals are expected to occupy larger share (45%) of the overall market (in terms of service-based revenues), by 2035. For additional details, please visit https://www.rootsanalysis.com/reports/rna-sequencing-services-market.html or email sales@rootsanalysis.com You may also be interested in the following titles: 1. Targeted protein degradation market, 2022-2035 2. Cell Therapy Manufacturing Market, 2021-2030 3. Single-Use Upstream Bioprocessing Technology / Equipment Market, 2022-2035 About Roots Analysis Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com Contact: Ben Johnson +1 (415) 800 3415 +44 (122) 391 1091 Ben.johnson@rootsanalysis.com Facebook - https://www.facebook.com/RootsAnalysis LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/ Twitter - https://twitter.com/RootsAnalysis Medium - https://medium.com/@RootsAnalysis Pinterest - https://in.pinterest.com/RootsanalysisPin/_saved/ Quora - https://rootsanalysisinsights.quora.com/ [more]
First Previous 5 6 7 8 9 10 11 12 13 14 Next Last